Back to Trades
Burrows Scott L
Chief Financial OfficerCIK 0001853327
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 16
- Companies
- 1
- Active
- 2025–2026
Burrows Scott L, Chief Financial Officer, has filed 9 SEC reports (2025–2026), all concentrated in Spyre Therapeutics, Inc. (SYRE), totaling $10.9M in disclosed volume. Weighing $0 bought versus $4.9M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Aug 5 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $716.8K |
| Jul 2 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $658.0K |
| Jun 26 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $1.3M |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $532.9K |
| May 1 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $892.1K |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $370.1K |
| Mar 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $101.6K |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Award | $4.3M |
| Sep 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $299.6K |
9 filings